Hemorrhagic disseminated intravascular coagulation after (177)Lu-Dotatate in metastatic midgut neuroendocrine tumor: A case report

RATIONALE: Peptide receptor radionuclide therapy with (177)Lu-Dotatate represents a major breakthrough in the treatment of metastatic well differentiated neuroendocrine tumors. This treatment is generally well tolerated. Reported severe long-term hematological side effects are rare and include hemat...

Descripción completa

Detalles Bibliográficos
Autores principales: Worbe, Noémie, Damian, Louise, Le Cam-Duchez, Véronique, Levesque, Hervé, Michel, Pierre, Quak, Elske
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500554/
https://www.ncbi.nlm.nih.gov/pubmed/34622868
http://dx.doi.org/10.1097/MD.0000000000027455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500554/
https://www.ncbi.nlm.nih.gov/pubmed/34622868
http://dx.doi.org/10.1097/MD.0000000000027455

Ejemplares similares